Ftse Mib
34.160,97
1,25%
DAX
19.984,32
0,74%
S&P 500
5.970,84
-1,11%
NASDAQ
19.722,03
-1,49%
Bitcoin
94.255,89
0,10%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vir Biotechnology Inc (VIR) Vir Biotechnology Inc (VIR) Notizie

Vir Biotechnology Inc

VIR
7,50
0,10 (1,35%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 00:52:55
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202415:30BWVir Biotechnology to Present at the 43rd Annual J.P. Morgan..
12/12/202422:05BWVir Biotechnology Receives FDA Breakthrough Therapy..
04/12/202421:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202423:08EDGAR2Form 144 - Report of proposed sale of securities
26/11/202415:30BWVir Biotechnology to Host Virtual Investor Event on..
25/11/202415:30BWVir Biotechnology to Participate in the 7th Annual Evercore..
19/11/202403:15BWVir Biotechnology Presents Positive Chronic Hepatitis Delta..
18/11/202422:05BWVir Biotechnology Receives Positive Opinion on Orphan Drug..
18/11/202419:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202417:00BWVir Biotechnology Announces Positive End-of-Treatment..
08/11/202401:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202422:55EDGAR2Form 144 - Report of proposed sale of securities
05/11/202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:23EDGAR2Form 144 - Report of proposed sale of securities
04/11/202422:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202421:20EDGAR2Form 8-K - Current report
31/10/202421:05BWVir Biotechnology Reports Third Quarter 2024 Financial..
17/10/202422:30BWVir Biotechnology to Provide Business Update and Report..
15/10/202414:16BWVir Biotechnology Announces Clinical Advances Across..
03/10/202423:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/10/202422:00BWVir Biotechnology to Participate in the H.C. Wainwright 5th..
02/10/202418:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/10/202418:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/9/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202414:10EDGAR2Form 8-K - Current report
10/9/202414:05BWVir Biotechnology Appoints Jason O’Byrne as Chief Financial..
09/9/202422:29EDGAR2Form 144 - Report of proposed sale of securities
09/9/202422:05BWVir Biotechnology Announces Closing of Exclusive Worldwide..
22/8/202414:05BWVir Biotechnology to Participate in the Morgan Stanley 22nd..
01/8/202422:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202422:10EDGAR2Form 8-K - Current report
01/8/202422:08EDGAR2Form 8-K - Current report
01/8/202422:02BWVir Biotechnology Reports Second Quarter 2024 Financial..
01/8/202422:01BWVir Biotechnology Acts on Expanded Strategy of Powering the..
18/7/202422:05BWVir Biotechnology to Report Second Quarter 2024 Financial..
16/7/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/6/202414:05BWVir Biotechnology Receives FDA IND Clearance and Fast Track..
12/6/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202412:04EDGAR2Form 8-K - Current report
05/6/202411:30BWTobevibart Monotherapy and Combination Therapy with..
03/6/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202417:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/5/202420:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/5/202420:42EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/5/202422:06EDGAR2Form 8-K - Current report
29/5/202422:05BWVir Biotechnology to Participate in the Goldman Sachs 45th..
29/5/202414:05BWVir Biotechnology Appoints Mark Eisner, M.D., M.P.H. as..
23/5/202422:05BWVir Biotechnology to Host 2024 Annual Meeting of..
22/5/202414:05BWMultiple Abstracts Highlighting Vir Biotechnology’s Latest..
21/5/202414:17BWVir Biotechnology Announces SOLSTICE Data to be Featured as..
Apertura: 7,37 Min: 7,33 Max: 7,64
Chiusura: 7,40

La tua Cronologia

NASDAQ
VIR
Vir Biotechnology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network